KNSA vs TPR · P/E 53, rev $677.6M vs P/E 46, rev $8.00B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the KNSA and TPR stock pages for the full models.
Not investment advice.